Gengania, Luke David R.
HRN: 22-69-98 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2023
CEFTRIAXONE 1G (VIAL)
03/08/2023
03/14/2023
IV
1.5g
OD
URTI
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaURTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes